Navigation Links
Abbott Announces Continued Positive Results with Xience V,Everolimus Eluting Coronary Stent in Spirit Clinical Trials

is designed, studied and manufactured by Abbott Vascular. Abbott supplies a private-labeled version of XIENCE V to Boston Scientific, called the PROMUS(TM) Everolimus-Eluting Coronary Stent System, as part of a distribution agreement established between the two companies last year.

About the SPIRIT Family of Trials

SPIRIT FIRST is a randomized trial comparing the XIENCE V Everolimus Eluting Coronary Stent System with the MULTI-LINK VISION metallic stent system. SPIRIT II was a randomized clinical trial evaluating XIENCE V versus TAXUS in Europe and Asia Pacific. Professor Patrick Serruys of Rotterdam is the principal investigator in SPIRIT FIRST and SPIRIT II.

SPIRIT III is a large-scale randomized pivotal clinical trial comparing XIENCE V to TAXUS in the United States and Japan. SPIRIT IV is a randomized trial currently enrolling patients and will evaluate the safety and efficacy of XIENCE V for the treatment of coronary artery disease in a more complex patient population in the United States. Professor Gregg Stone of Medical Center, N.Y., is the principal investigator in SPIRIT III and SPIRIT IV.

SPIRIT V is an international clinical trial currently enrolling patients that will provide additional data on clinical experience with XIENCE V at 100 clinical sites throughout Europe, Asia, Canada and Latin America.

SPIRIT WOMEN is the world's first drug-eluting stent trial to study only women and will evaluate the characteristics of women undergoing stent implantation as well as the performance of XIENCE V in those patients in Europe, Asia-Pacific, Canada and Latin America.

For images of Abbott's investigational XIENCE V stent system and other information, please visit the company's online newsroom at http://www.abbottvascular.com/presskit.

About Abbott Vascular

Abbott Vascular, a division of Abbott, is one of the world's leading vascular care bu
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
4. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
5. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
6. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/30/2009)... Reportlinker.com announces that a...talogue: ,, Decubitus Ulcer Treatment Products...portlinker.com/p0164283/Decubitus-Ulcer-Treatment-...Decubitus Ulcers are lesions resulting from tissue...,s bodyweight. Pressure ulcer treatment products v...
(Date:11/30/2009)... The Simmons law firm,s Trent Mira...nting thousands of women that were seriously injur...ntrol pill manufactured and marketed by Bayer Phar...idistrict Litigation has ordered that all federal ...olidated and centralized for pretrial litigation i...
(Date:11/30/2009)...Newswire/ -- Minimally-invasive procedures are inc...icularly in oncology, cardiology and women,s healt...ided navigation expected to reach $600 million by ...red by minimally-invasive procedures, including sh...ort and faster patient throughput. ,, (Logo: ...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges 51471 1Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges 51471 2Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 1Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 2Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 3Golds Gym Debunks Americas Most Common Fitness Myths 51465 1Golds Gym Debunks Americas Most Common Fitness Myths 51465 2Golds Gym Debunks Americas Most Common Fitness Myths 51465 3
...opharmaceuticals,announced today that the last sub...l trial has completed their scheduled 8 month visi...of this pivotal clinical trial of its,investigatio...he treatment,of subjects with type 2 diabetes and ... the maximum approved or tolerated dose of either ...
...rnal of Immunology, SEATTLE, Feb. 11 Cell Therap...ed that pixantrone was shown to reduce,the severit... the,autoimmune disease myasthenia gravis (MG). MG...racterized by varying degrees of weakness of the,s...oantibodies acting,against the Acethylcholine Rece...
Other Medicine Technology:Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial 2Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial 3Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial 4Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial 5Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG) 2Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG) 3Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG) 4
(Date:11/30/2009)... In study, athletes had ,younger, immune cells tha...Y, Nov. 30 (HealthDay News) -- Studies have shown ...cancer, and now new research shows that the reason...Endurance athletes had longer telomeres -- DNA at ...n their white blood cells than healthy, nonsmoking...
(Date:11/30/2009)..., , NEW ORLEANS, Nov. 30 /PRNewswire-USNe... employees of the global corporation Sodexo will h...xo Facilities and Maintenance headquarters, 3800 D...able leave policy and arbitrary disciplinary polic...to care for an ill family member. Sodexo employees...
(Date:11/30/2009)..., , LOS ANGELES, Nov. 30 ...tino Decisions, the Robert Wood Johnson Foundation... Mexico (UNM-RWJF Center), and impreMedia, shows a...ectoral about the importance of health care reform...f coverage. For the first time, health care tops t...
(Date:11/30/2009)..., , SCHAFFHAUSEN, Switzerland, Nov. 30 /P...YSE: TYC ) today announced that its 2010 annual ...dnesday, March 10, 2010 at 3:00 p.m. Central Europ...-Strasse 21, 8002 Zurich, Switzerland. Registered ...te) will be entitled to vote at the annual general...
(Date:11/30/2009)..., , GAINESVILLE, Fla., Nov. 30 /PRNewswire...DynaCAD marks the availability of the first FDA-cl...e detection and analysis by a radiologist of suspi...icially unveiled at the Radiological Society of No...Developed in partnership with leading experts in b...
Breaking Medicine News(10 mins):Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3
... Nursing Career To The Next Level, AURORA, Colo.,...owing industries in the world, the demand for nurs...s to rise. To help Registered,Nurses (RNs) remain ...am., For many nurses looking to advance their car...
...US, Ohio Young children tend to think that other ...wear glasses, according to a new study. , Childre...or the study also thought that kids wearing glasse...eir peers who wear glasses when asked about their ...
...sability Insurance Awareness Month; LIFE Foundatio...le to Evaluate their Disability Insurance ...y 12 If you were unable to work,because of a long...t nearly 80 percent of working Americans say they,...
...r visiting from Japan specifically for event -, M... baby,harp seal more effective than real, live dog...eniors with dementia and other aging-related,illne...rts in aging from universities, corporations, heal...
...lished in Journal of Occupational and Environmenta...ts, Medication Adherence, and Health ...ay 12 High prescription drug,co-payments are asso... and Environmental Medicine. The study, funded by,...
..., Va.Using single-photon emission computed tomogra...ble to detect biochemical differences in the brain...isorder (also known as social phobia), providing e... compared densities of elements of the serotonin a...
Other Medicine News:Health News:American Sentinel University Accepting Enrollment in Online RN to BS in Nursing 2Health News:Study: Kids think eyeglasses make other kids look smart 2Health News:Study: Kids think eyeglasses make other kids look smart 3Health News:New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability, Would Rely on Sources Other than Themselves for Support 2Health News:New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability, Would Rely on Sources Other than Themselves for Support 3Health News:New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability, Would Rely on Sources Other than Themselves for Support 4Health News:Paro, the World's Only Robotic Baby Harp Seal - Designed Specifically for Therapy - to be Focus of Industry Event at Vinson Hall Retirement Community in McLean, Va., June 2 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 3Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 4Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 5Health News:Are anxiety disorders all in the mind? 2
...ver systems to a new level of technological sophis...SL. Just the latest product offering from KARL STO...owershaver SL represents our commitment to the imp...c surgery. ,Whether the application is knee, shou...
...into the digital age to document surgical procedur...andard surgical video cart, the SOLOS Digital Inte...document and archive surgical and diagnostic image... referrals, teaching and training. The DIS2000 pro...
Linvatec Single CCD Camera Head
8180 Series Customized Digital Camera System
Medicine Products: